Issue Date: August 11, 2014
Biotechs Beat Pharma In First-Half Earnings
Boosted by successful new products, large biotech firms outperformed their big pharma counterparts in the first half of 2014. Major drug firms, experiencing a continued drop in sales and earnings, resorted to quick fixes to try to solve their growth problems.
Of the 11 major drug firms tracked by C&EN, only four saw an increase in sales during the first half of the year. And none managed to achieve the double-digit sales growth that a . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society